Terms: = Colorectal cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
170 results:
1. Nomograms integrating the collagen signature and systemic immune-inflammation index for predicting prognosis in rectal cancer patients.
Yu X; Jiang W; Dong X; Yan B; Xu S; Lin Z; Zhuo S; Yan J
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38513282
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
3. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
Li X; Li J; Li J; Liu N; Zhuang L
BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
[TBL] [Abstract] [Full Text] [Related]
5. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
[TBL] [Abstract] [Full Text] [Related]
6. Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV.
Pietrantonio F; Bergamo F; Rossini D; Ghelardi F; De Grandis MC; Germani MM; Barsotti G; Formica V; Frassineti GL; Boscolo G; Cinieri S; Di Donato S; Antonuzzo L; Antoniotti C; Ambrosini M; Piva VM; Nichetti F; Fassan M; Cremolini C; Lonardi S
Eur J Cancer; 2023 Dec; 195():113396. PubMed ID: 37924647
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics and outcomes of rectal cancer in patients with inflammatory bowel disease: a single-center experience.
Emile SH; Horesh N; Garoufalia Z; Rogers P; Gefen R; Dasilva G; Wexner SD
Updates Surg; 2024 Jan; 76(1):119-126. PubMed ID: 37814150
[TBL] [Abstract] [Full Text] [Related]
8. A Meta-Analysis to Assess the Efficacy of HER2-Targeted treatment Regimens in HER2-Positive Metastatic colorectal cancer (mCRC).
Chitkara A; Bakhtiar M; Sahin IH; Hsu D; Zhang J; Anamika F; Mahnoor M; Ahmed R; Gholami S; Saeed A
Curr Oncol; 2023 Sep; 30(9):8266-8277. PubMed ID: 37754515
[TBL] [Abstract] [Full Text] [Related]
9. Targeted Therapy for cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.
Choi HY; Chang JE
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686423
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis of prognosis and related factors in oldest-old patients with left-side or right-side colon cancer after hemicolectomy].
An Q; Shi JX; Cui J; Li ZJ; Ma FH; Xiao G; Jia WW; Tang DN; Zhao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1666-1672. PubMed ID: 37302856
[No Abstract] [Full Text] [Related]
11. Factors Affecting the Efficacy of Regorafenib in Metastatic colorectal cancer: Is Tumour Sidedness Important?
Kazaz SN; Ozdover AC; Usta N; Yildirim A; Fidan E; Ozdemir F
J Coll Physicians Surg Pak; 2023 Jun; 33(6):659-665. PubMed ID: 37300262
[TBL] [Abstract] [Full Text] [Related]
12. SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Drilon A; Sharma MR; Johnson ML; Yap TA; Gadgeel S; Nepert D; Feng G; Reddy MB; Harney AS; Elsayed M; Cook AW; Wong CE; Hinklin RJ; Jiang Y; Brown EN; Neitzel NA; Laird ER; Wu WI; Singh A; Wei P; Ching KA; Gaudino JJ; Lee PA; Hartley DP; Rothenberg SM
Cancer Discov; 2023 Aug; 13(8):1789-1801. PubMed ID: 37269335
[TBL] [Abstract] [Full Text] [Related]
13. Timing of rectal cancer surgery after short-course radiotherapy: national database study.
Verweij ME; Franzen J; van Grevenstein WMU; Verkooijen HM; Intven MPW
Br J Surg; 2023 Jun; 110(7):839-845. PubMed ID: 37172197
[TBL] [Abstract] [Full Text] [Related]
14. Mutations in Classical Signaling Pathways and Their Functional Impact in Microsatellite Instability High colorectal cancer.
Shi S; Gong Y; Li X; Ding Y; Song G; Liu H; Zhang Z
Genet Test Mol Biomarkers; 2023 Mar; 27(3):90-99. PubMed ID: 36989521
[No Abstract] [Full Text] [Related]
15. Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab.
Li S; Yuan L; Yue M; Xu Y; Liu S; Wang F; Liu X; Wang F; Deng J; Sun Q; Liu X; Xue C; Lu T; Zhang W; Zhou J
Cancer Imaging; 2023 Mar; 23(1):30. PubMed ID: 36964617
[TBL] [Abstract] [Full Text] [Related]
16. Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::alk fusion responding to alectinib.
Sunga CGG; Higgins MS; Ricciotti RW; Liu YJ; Cranmer LD
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1792. PubMed ID: 36754839
[TBL] [Abstract] [Full Text] [Related]
17. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
[TBL] [Abstract] [Full Text] [Related]
18. Association of Radiation and Procarbazine Dose With Risk of colorectal cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract] [Full Text] [Related]
19. Recent Updates on Structural Aspects of alk Inhibitors as an Anticancer Agent.
Ayaz MS; Bhupal R; Sharma P; Sahu A; Singh P; Gupta GD; Asati V
Anticancer Agents Med Chem; 2023; 23(8):900-921. PubMed ID: 36627781
[TBL] [Abstract] [Full Text] [Related]
20. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
[TBL] [Abstract] [Full Text] [Related]
[Next]
